Provista Life Sciences has recently announced the availability of its Biomarker Translation test or BT test, a blood test specifically designed to assist physicians and other healthcare providers in making an earlier and more accurate diagnosis of breast cancer when used in conjunction with mammography.
William Gartner, CEO and president of Provista, said: “Until now, doctors prescribing the test and patients wishing to take the BT test were limited to our central Phoenix laboratory, Provista Diagnostics, for their blood draws. With Sonora’s support, we can now make the BT test more readily accessible to women across all of Arizona.”